Metastatic Adrenocortical Carcinoma With a Prolonged Response to Mitotane
Published: | Updated:
Adrenocortical carcinoma is a rare disease, with an annual incidence rate ranging from 0.5 to 2.0 cases per million individuals.
Benjamin Gartrell, MD
Advertisement
Articles by Benjamin Gartrell, MD
Advertisement
Latest Updated Articles
Metastatic Adrenocortical Carcinoma With a Prolonged Response to MitotanePublished: July 15th 2014 | Updated: November 11th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
Adding SBRT to Ipilimumab/Nivolumab Does Not Improve PFS in Advanced RCC
2
Potential Iberdomide Approval May Offer Another Choice in Multiple Myeloma
3
Molecular Interception: Discussing the Future of Surgery in Breast Cancer
4
Examining Pembrolizumab Combo Safety in High-Risk Prostate Cancer
5